An advisory committee for the FDA will vote today on whether to recommend a peanut allergy treatment for FDA approval.
An advisory committee for the Food and Drug Administration will vote today on whether to recommend a peanut allergy treatment for FDA approval.Palforzia is a type of oral immunotherapy. The treatment involves exposing children with peanut allergies to increasing doses of peanut protein, in order to build up tolerance over time. The goal of the treatment is not to get rid of a peanut allergy entirely, but to reduce a person’s risk of severe reactions in case of accidental exposures.
“From a science standpoint, this is a breakthrough,” said Dr. Bruce Lanser, a pediatric allergist and immunologist and director of the pediatric food allergy program at National Jewish Health in Denver. Lanser ran one arm of the clinical trials on the treatment. Erin Sorce, of Denver, agreed. Her 13-year-old son Colton participated in a clinical trial for separate but similar peanut allergy treatment.
“I feel like this would be revolutionary,” Sorce said. “The thought of kids having access to something like that brings tears to my eyes.”
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
HHS Secretary Alex Azar: FDA will finalize new e-cigarette rulesAlex Azar, Secretary of Health and Human Services, and acting FDA commissioner Ned Sharpless make comments the Trump administration will be banning flavored non-tobacco e-cigarettes.
Consulte Mais informação »
Trump & FDA Move To Ban Flavored E-Cigs After Vaping-Related DeathsToday, the Trump administration announced it is moving to ban flavored e-cigarette products in response to use by minors and vaping-related illnesses.
Consulte Mais informação »
Juul says it will keep running 'Make the Switch' ad campaign despite FDA concernsThe FDA sent Juul a warning letter this week about its campaign urging people to 'Make the Switch' from cigarettes, but the company isn't backing down.
Consulte Mais informação »
Column: A stem cell clinic under fire by the FDA and ex-patients files for bankruptcyA La Jolla clinic pitching $15,000 stem cell treatments files for bankruptcy, facing a lawsuit from former patients.
Consulte Mais informação »
FDA finds impurity in popular heartburn medicine Zantac that could cause cancerThe FDA has learned that Sanofi's heartburn medication Zantac carries a substance that could cause cancer.
Consulte Mais informação »
GE Healthcare earned FDA clearance for its AI-powered portable x-rayGE Healthcare earned the FDA's approval for its AI-powered mobile X-ray device – marking the first time the FDA has cleared a tool of its kind.
Consulte Mais informação »